This inventor holds 2 USPTO granted patents. Top assignees: Duke University, Other. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,078 
1 out of 834,453 Years Active: 2000-2003
Title: E Magnus Ohman: Innovator in Cardiac Therapy Evaluation
Introduction
E Magnus Ohman is a notable inventor based in Durham, NC (US), recognized for his contributions to the field of cardiac therapy evaluation. He holds 2 patents that focus on methods for predicting clinical outcomes related to coronary conditions. His work has significant implications for improving patient care in acute coronary syndrome scenarios.
Latest Patents
Ohman's latest patents include innovative methods that enhance the evaluation of therapies for patients suffering from coronary conditions. One of his patents outlines a method for predicting clinical outcomes after therapy for acute coronary syndrome, such as myocardial infarction. This method involves detecting various serum creatine kinase-MB release curve variables to generate predictions about patient outcomes. Another patent focuses on diagnosing persistent occlusions in myocardial infarct patients undergoing thrombolytic therapy. This method assesses multiple variables, including serum CK-MB levels and the presence of chest pain, to determine the likelihood of a persistent occlusion.
Career Highlights
Throughout his career, E Magnus Ohman has made significant strides in the medical field, particularly in cardiology. His work has been instrumental in developing methods that aid in the assessment of therapy effectiveness and patient prognosis. He has collaborated with esteemed institutions, including Duke University, to further his research and innovations.
Collaborations
Ohman has worked alongside notable professionals in the field, including Robert H Christenson and Robert M Califf. Their collaborations have contributed to advancing cardiac care and improving therapeutic strategies.
Conclusion
E Magnus Ohman is a distinguished inventor whose work in cardiac therapy evaluation has the potential to transform patient outcomes. His innovative methods and collaborations highlight his commitment to advancing medical science and improving healthcare practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile